Open AccessThe role of interleukin‐18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome – a systematic review
Author(s) -
Krei J. M.,
Møller H. J.,
Larsen J. B.
Publication year - 2021
Publication title -
clinical & experimental immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 135
eISSN - 1365-2249
pISSN - 0009-9104
DOI - 10.1111/cei.13543
Subject(s) - macrophage activation syndrome , hemophagocytic lymphohistiocytosis , medicine , immunology , biomarker , interleukin 18 , arthritis , cytokine , disease , biology , biochemistry
Systematic review of studies investigating interleukin‐18 (IL‐18) in hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS).Serum IL‐18 appears to discriminate well between HLH/MAS and other inflammatory conditions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom